Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Behind-The-Counter Sale Works Without Regulation – Former FDA Counsel

This article was originally published in The Tan Sheet

Executive Summary

FDA's interest in establishing an official third class of drugs, as well as the OTC industry's concern about the idea, could be diminished because the agency already allows a path to behind-the-counter sales in new drug and switch applications, according to a former FDA chief counsel
Advertisement

Related Content

Behind-The-Counter Sale Is No Deterrent To Brand Loyalty – Survey
Behind-The-Counter Sale Is No Deterrent To Brand Loyalty – Survey
Behind-The-Counter Sale Is No Deterrent To Brand Loyalty – Survey
Von Eschenbach Promotes Behind-The-Counter Drug Class
Alli Approved OTC For Weight Loss With “Goal Oriented” Indication
Plan B Pioneers OTC “Pharmacy Counter” Approval, Dual-Status Marketing
FDA Memo Sheds Light On Plan B Discussions
FDA Memo Sheds Light On Plan B Discussions
Prilosec OTC Approved In 28-, 42-Count Multiple Regimen Sizes

Topics

Advertisement
UsernamePublicRestriction

Register

PS100369

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel